Therapeutic considerations in an 8-year-old girl with clear cell adenocarcinoma of the cervix

Journal of Gynecologic Surgery

Volumn 13, Issue 1, 1997, Pages 31-34

  Wesolowski, Judy A ^a   Adelson, Mark D ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b Comprehensive Gynecology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; DIETHYLSTILBESTROL; PACLITAXEL;

ADENOCARCINOMA; ARTICLE; CANCER INVASION; CANCER RADIOTHERAPY; CASE REPORT; CHILD; CLEAR CELL CARCINOMA; FEMALE; FEMALE FERTILITY; HUMAN; LIFE EXPECTANCY; MORBIDITY; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA;

EID: 0030914071     PISSN: 10424067     EISSN: None     Source Type: Journal    
DOI: 10.1089/gyn.1997.13.31     Document Type: Article

References (14)

1. Noller KL, Decker DG, Symmonds RE, Dockery MB, Kurland LT. Clear-cell adenocarcinoma of the vagina and cervix: Survival data. Am J Obstet Gynecol 1976;124:285.
2. Herbst AL, Andersen D. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol. Semin Surg Oncol 1990;6:343.
3. Herbst AL. Diethlystibestrol and other sex hormones during pregnancy. Obstet Gynecol 1981;58:35S.
4. Melnick L, Cole P, Anderson D, Herbst AL. Rates and risks of diethlystilbestrol-related clear cell adenocarcinoma of the vagina and cervix. N Engl J Mod 1987;316:514.
5. Gunning JE. The DES story. Obstet Gynecol Surv 1976;31:827.
6. Herbst AL, Anderson S, Hubby MM, Haenszel WM, Noller KL. Risk factors for the development of diethylstilbestrol-associated clear cell adenocarcinoma: A case-control study. Am J Obstet Gynecol 1986;154:814.
7. Alvarez RD, Gelder MS, Gore H, Soong SJ, Patridge EE. Radical hysterectomy in the treatment of patients with bulky early stage carcinoma of the cervix uteri. Surg Gynecol Obstet 1993;176:539.
8. Saigo PE, Cain JM, Kim WS, Gaynor JJ, Johnson K, Lewis JL. Prognostic factors in adenocarcinoma of the uterine cervix. Cancer 1986;57:1584.
9. Gerbaulet AP, Esche BA, Haie CM, Castaigne D, Flamant F, Chassagne D. Conservative treatment for lower gynecological tract malignancies in children and adolescents: The Institut Gustave-Roussy experience. Int J Radiat Oncol Biol Phys 1989;17:655.
10. Robboy SJ, Herbst AL, Scully RE. Clear-cell adenocarcinoma of the vagina and cervix in young females: Analysis of 37 tumors that persisted or recurred after primary therapy. Cancer 1974;34:606.
11. Kaminski PF, Maier RC. Clear cell adenocarcinoma of the cervix unrelated to diethystilbestrol exposure. Obstet Gynecol 1983;62:720.
12. Hopkins MP, Schmidt RW, Roberts JA, Morley GW. The prognosis and treatment of stage I adenocarcinoma of the cervix. Obstet Gynecol 1988;72:915.
13. Senekjian EK, Frey K, Herbst AL. Pelvic exenteration in clear cell adenocarcinoma of the vagina and cervix. Gynecol Oncol 1989;34:413.
14. McLellan R, Dillon MB, Woodruff JD, Heatley GJ, Fields AL, Rosenshein NB. Long-term follow-up of stage I cervical adenocarcinoma treated by radical surgery. Gynecol Oncol 1994;52(2):253.